Sonnet BioTherapeutics Holdings, Inc. (SONN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.76M | -2.47M | -2.91M | -3.17M | -3.07M | 723.79K | -3.09M | -4.56M | -6.17M | -4.7M | -5.92M | -6.16M |
| Operating CF Margin % | - | - | -291.02% | - | - | - | -16599.04% | -12237.59% | -16749.05% | -12883.89% | -15877.52% | -9818.95% |
| Operating CF Growth % | 42.7% | -441.43% | 5.87% | 30.47% | 50.27% | 115.41% | 47.73% | 26.01% | 21.12% | 16.28% | 26.9% | -3.76% |
| Net Income | -3.78M | -3.49M | -3.16M | -3.13M | -3.51M | 365.43K | -1.17M | -3.68M | -3.95M | -5.67M | -5.54M | -7.44M |
| Depreciation & Amortization | 22.16K | 22.09K | 22.19K | 21.61K | 21.04K | 20.5K | 19.97K | 19.47K | 18.98K | 18.87K | 18.43K | 17.93K |
| Stock-Based Compensation | 0 | 0 | 60.4K | -170.79K | 60.4K | 60.4K | 50.01K | 50.01K | 50.01K | 57K | 91.62K | 85.51K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 36.77K | -368.62K | 368.62K | 0 | 0 | 0 |
| Other Non-Cash Items | 138.32K | 487.32K | 12K | 231.19K | 372.16K | 0 | -24.77K | 368.62K | -198.62K | 12K | 100K | 99.6K |
| Working Capital Changes | 1.86M | 510.44K | 155.87K | -123.58K | -17.64K | 277.48K | -2.01M | -951.85K | -2.46M | 883.67K | -583.08K | 1.07M |
| Change in Receivables | 180.8K | -611.4K | 95.29K | -242.47K | -141.65K | -183.85K | 592.46K | -37.41K | -302.16K | 889.41K | -619.12K | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37.41K | 302.16K | -889.41K | 619.12K | 0 |
| Change in Payables | 2M | 181.1K | -635.57K | 503.46K | -86.36K | 97.05K | -465.74K | -753.99K | -1.49M | -11.44K | -375.54K | 1.73M |
| Cash from Investing | 0 | -12K | 0 | 0 | -12K | 0 | 0 | -170K | -12K | -261.25K | 0 | -24.6K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -170K | -12K | -261.25K | 0 | -24.6K |
| CapEx % of Revenue | - | - | - | - | - | - | 0.02% | 456.31% | 32.56% | 716.83% | - | 39.2% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -12K | 0 | 0 | -12K | 0 | 0 | 0 | -12K | 0 | 0 | 61.65K |
| Cash from Financing | 21.05K | -318.96K | 7.62M | -234.71K | 2.85M | 41K | 3.84M | -17.7K | 1.81M | 14.65M | 4.56M | 4.01M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 41.05K | 51.24K | 1000K | -21.78K | 60.29K | 56K | 1000K | -17.7K | 0 | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -20K | -370.2K | -88.87K | -212.93K | 2.79M | -15K | 0 | 0 | 1.81M | 0 | 0 | 2.17M |
| Net Change in Cash | -1.74M | -2.8M | 4.71M | -3.4M | -231.85K | 764.79K | 747.13K | -4.75M | -4.37M | 9.69M | -1.35M | -2.17M |
| Free Cash Flow | -1.76M | -2.47M | -2.91M | -3.17M | -3.08M | 723.79K | -3.09M | -4.73M | -6.18M | -4.96M | -5.92M | -6.19M |
| FCF Margin % | - | - | -291.02% | - | - | - | -16599.04% | -12693.9% | -16781.61% | -13600.72% | -15877.52% | -9858.15% |
| FCF Growth % | 42.92% | -441.43% | 5.87% | 32.96% | 50.17% | 114.6% | 47.73% | 23.55% | 26.48% | 14.16% | 27.97% | -4.12% |
| FCF per Share | -0.44 | -0.63 | -1.44 | -4.88 | -4.89 | 1.25 | -6.51 | -21.61 | -37.05 | -52.83 | -150.43 | -243.10 |
| FCF Conversion (FCF/Net Income) | 0.47x | 0.71x | 0.92x | 1.01x | 0.88x | 1.98x | 2.65x | 1.24x | 1.56x | 0.83x | 1.07x | 0.82x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |